It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The increase in speed of the high-speed atomic force microscopy (HS-AFM) compared to that of the conventional AFM made possible the first-ever visualisation at the molecular-level of the activity of an antimicrobial peptide on a membrane. We investigated the medically prescribed but poorly understood lipopeptide Daptomycin under infection-like conditions (37 °C, bacterial lipid composition and antibiotic concentrations). We confirmed so far hypothetical models: Dap oligomerization and the existence of half pores. Moreover, we detected unknown molecular mechanisms: new mechanisms to form toroidal pores or to resist Dap action, and to unprecedently quantify the energy profile of interacting oligomers. Finally, the biological and medical relevance of the findings was ensured by a multi-scale multi-nativeness—from the molecule to the cell—correlation of molecular-level information from living bacteria (Bacillus subtilis strains) to liquid-suspended vesicles and supported-membranes using electron and optical microscopies and the lipid tension probe FliptR, where we found that the cells with a healthier state of their cell wall show smaller membrane deformations.
High-speed atomic force imaging allows for the visualisation of molecular‐level activity in real-time. Here, the authors use HS-AFM to image the activity of an antimicrobial peptide on a membrane and are able to detect previously unknown molecular mechanisms behind its action.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details



1 U1067 INSERM, Aix-Marseille Université, Marseille, France (GRID:grid.5399.6) (ISNI:0000 0001 2176 4817)
2 University of Geneva, Biochemistry Department, Geneva, Switzerland (GRID:grid.8591.5) (ISNI:0000 0001 2322 4988)
3 University of Geneva, Organic Chemistry Department, Geneva, Switzerland (GRID:grid.8591.5) (ISNI:0000 0001 2322 4988)
4 Department of Technical Informatics University of Szeged, Szeged, Hungary (GRID:grid.9008.1) (ISNI:0000 0001 1016 9625)
5 Laboratoire de Chimie Bactérienne (LCB), Institut de Microbiologie de la Méditerranée (IMM), CNRS, UMR 7283, Aix Marseille Université, Marseille, France (GRID:grid.469471.9) (ISNI:0000 0004 0369 4095)
6 University of Szeged, Institute of Environmental Science and Engineering, Szeged, Hungary (GRID:grid.9008.1) (ISNI:0000 0001 1016 9625)
7 LISM, UMR 7255, CNRS, Aix Marseille Université, Marseille, France (GRID:grid.5399.6) (ISNI:0000 0001 2176 4817)